{"entity":{"type":"insider","cik":"0001578850","url":"/insider/0001578850","json_url":"/insider/0001578850.json","name":"Almstead Neil Gregory","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":154,"n_filings":47,"first":"2014-03-20","last":"2026-07-13","span_basis":"filed_date"},"name_variants":[{"name":"Almstead Neil Gregory","source":"filing","n_filings":47,"first_seen":"2014-03-20","last_seen":"2026-07-13"}],"transactions":[{"id":6213383,"accession":"0001578850-26-000023","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001578850-26-000023","line_url":"/filing/0001578850-26-000023#line-2","is_derivative":false,"issuer_cik":"0001070081","issuer_name":"PTC THERAPEUTICS, INC.","issuer_ticker":"PTCT","issuer_name_source":null,"issuer_url":"/issuer/0001070081","owner_cik":"0001578850","owner_name":"Almstead Neil Gregory","owner_display_name":"Almstead Neil Gregory","owner_url":"/insider/0001578850","role":"Officer (CHIEF TECHNICAL OPS OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF TECHNICAL OPS OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF TECHNICAL OPS OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2464.0,"shares_display":"2,464","price_per_share":90.25,"price_display":"90.25","price_state":"stated","total_value":222376.0,"total_display":"222,376.00","total_whole":"222,376","shares_owned_after":60299.0,"shares_owned_after_display":"60,299","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-07-09","filed_date":"2026-07-13","scope":"insider"},{"id":6186875,"accession":"0001578850-26-000021","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0001578850-26-000021","line_url":"/filing/0001578850-26-000021","is_derivative":false,"issuer_cik":"0001070081","issuer_name":"PTC THERAPEUTICS, INC.","issuer_ticker":"PTCT","issuer_name_source":null,"issuer_url":"/issuer/0001070081","owner_cik":"0001578850","owner_name":"Almstead Neil Gregory","owner_display_name":"Almstead Neil Gregory","owner_url":"/insider/0001578850","role":"Officer (CHIEF TECHNICAL OPS OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF TECHNICAL OPS OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF TECHNICAL OPS OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":24613.0,"shares_display":"24,613","price_per_share":88.88576402714013,"price_display":"88.89","price_state":"stated","total_value":2187745.31,"total_display":"2,187,745.31","total_whole":"2,187,745","shares_owned_after":69587.0,"shares_owned_after_display":"69,587","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-07-07","filed_date":"2026-07-08","scope":"insider","n_lines":3},{"id":6186860,"accession":"0001578850-26-000021","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001578850-26-000021","line_url":"/filing/0001578850-26-000021","is_derivative":false,"issuer_cik":"0001070081","issuer_name":"PTC THERAPEUTICS, INC.","issuer_ticker":"PTCT","issuer_name_source":null,"issuer_url":"/issuer/0001070081","owner_cik":"0001578850","owner_name":"Almstead Neil Gregory","owner_display_name":"Almstead Neil Gregory","owner_url":"/insider/0001578850","role":"Officer (CHIEF TECHNICAL OPS OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF TECHNICAL OPS OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF TECHNICAL OPS OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":22161.0,"shares_display":"22,161","price_per_share":85.99504986237083,"price_display":"86.00","price_state":"stated","total_value":1905736.3,"total_display":"1,905,736.30","total_whole":"1,905,736","shares_owned_after":60299.0,"shares_owned_after_display":"60,299","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-07-06","filed_date":"2026-07-08","scope":"insider","n_lines":5},{"id":5813744,"accession":"0001578850-26-000019","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001578850-26-000019","line_url":"/filing/0001578850-26-000019","is_derivative":false,"issuer_cik":"0001070081","issuer_name":"PTC THERAPEUTICS, INC.","issuer_ticker":"PTCT","issuer_name_source":null,"issuer_url":"/issuer/0001070081","owner_cik":"0001578850","owner_name":"Almstead Neil Gregory","owner_display_name":"Almstead Neil Gregory","owner_url":"/insider/0001578850","role":"Officer (CHIEF TECHNICAL OPS OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF TECHNICAL OPS OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF TECHNICAL OPS OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8130.0,"shares_display":"8,130","price_per_share":85.25847970479705,"price_display":"85.26","price_state":"stated","total_value":693151.44,"total_display":"693,151.44","total_whole":"693,151","shares_owned_after":60137.0,"shares_owned_after_display":"60,137","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-26","filed_date":"2026-06-30","scope":"insider","n_lines":2},{"id":6149279,"accession":"0001578850-26-000017","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0001578850-26-000017","line_url":"/filing/0001578850-26-000017","is_derivative":false,"issuer_cik":"0001070081","issuer_name":"PTC THERAPEUTICS, INC.","issuer_ticker":"PTCT","issuer_name_source":null,"issuer_url":"/issuer/0001070081","owner_cik":"0001578850","owner_name":"Almstead Neil Gregory","owner_display_name":"Almstead Neil Gregory","owner_url":"/insider/0001578850","role":"Officer (CHIEF TECHNICAL OPS OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF TECHNICAL OPS OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF TECHNICAL OPS OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20960.0,"shares_display":"20,960","price_per_share":85.96644465648855,"price_display":"85.97","price_state":"stated","total_value":1801856.68,"total_display":"1,801,856.68","total_whole":"1,801,857","shares_owned_after":60137.0,"shares_owned_after_display":"60,137","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-25","filed_date":"2026-06-26","scope":"insider","n_lines":5},{"id":6149254,"accession":"0001578850-26-000017","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001578850-26-000017","line_url":"/filing/0001578850-26-000017","is_derivative":false,"issuer_cik":"0001070081","issuer_name":"PTC THERAPEUTICS, INC.","issuer_ticker":"PTCT","issuer_name_source":null,"issuer_url":"/issuer/0001070081","owner_cik":"0001578850","owner_name":"Almstead Neil Gregory","owner_display_name":"Almstead Neil Gregory","owner_url":"/insider/0001578850","role":"Officer (CHIEF TECHNICAL OPS OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF TECHNICAL OPS OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF TECHNICAL OPS OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5323.0,"shares_display":"5,323","price_per_share":85.02849333082848,"price_display":"85.03","price_state":"stated","total_value":452606.67,"total_display":"452,606.67","total_whole":"452,607","shares_owned_after":60137.0,"shares_owned_after_display":"60,137","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-24","filed_date":"2026-06-26","scope":"insider","n_lines":2},{"id":5881980,"accession":"0001578850-26-000014","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001578850-26-000014","line_url":"/filing/0001578850-26-000014","is_derivative":false,"issuer_cik":"0001070081","issuer_name":"PTC THERAPEUTICS, INC.","issuer_ticker":"PTCT","issuer_name_source":null,"issuer_url":"/issuer/0001070081","owner_cik":"0001578850","owner_name":"Almstead Neil Gregory","owner_display_name":"Almstead Neil Gregory","owner_url":"/insider/0001578850","role":"Officer (CHIEF TECHNICAL OPS OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF TECHNICAL OPS OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF TECHNICAL OPS OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":23749.0,"shares_display":"23,749","price_per_share":80.90354499136805,"price_display":"80.90","price_state":"stated","total_value":1921378.29,"total_display":"1,921,378.29","total_whole":"1,921,378","shares_owned_after":71756.0,"shares_owned_after_display":"71,756","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-22","filed_date":"2026-06-24","scope":"insider","n_lines":2},{"id":5834880,"accession":"0001578850-26-000012","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001578850-26-000012","line_url":"/filing/0001578850-26-000012","is_derivative":false,"issuer_cik":"0001070081","issuer_name":"PTC THERAPEUTICS, INC.","issuer_ticker":"PTCT","issuer_name_source":null,"issuer_url":"/issuer/0001070081","owner_cik":"0001578850","owner_name":"Almstead Neil Gregory","owner_display_name":"Almstead Neil Gregory","owner_url":"/insider/0001578850","role":"Officer (CHIEF TECHNICAL OPS OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF TECHNICAL OPS OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF TECHNICAL OPS OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":52003.0,"shares_display":"52,003","price_per_share":69.03914716458665,"price_display":"69.04","price_state":"stated","total_value":3590242.77,"total_display":"3,590,242.77","total_whole":"3,590,243","shares_owned_after":72747.0,"shares_owned_after_display":"72,747","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-04-01","filed_date":"2026-04-03","scope":"insider","n_lines":3},{"id":6131156,"accession":"0001578850-26-000010","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001578850-26-000010","line_url":"/filing/0001578850-26-000010#line-1","is_derivative":false,"issuer_cik":"0001070081","issuer_name":"PTC THERAPEUTICS, INC.","issuer_ticker":"PTCT","issuer_name_source":null,"issuer_url":"/issuer/0001070081","owner_cik":"0001578850","owner_name":"Almstead Neil Gregory","owner_display_name":"Almstead Neil Gregory","owner_url":"/insider/0001578850","role":"Officer (CHIEF TECHNICAL OPS OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF TECHNICAL OPS OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF TECHNICAL OPS OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3989.0,"shares_display":"3,989","price_per_share":63.38,"price_display":"63.38","price_state":"stated","total_value":252822.82,"total_display":"252,822.82","total_whole":"252,823","shares_owned_after":2737.0,"shares_owned_after_display":"2,737","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-03-05","filed_date":"2026-03-09","scope":"insider"},{"id":5995013,"accession":"0001578850-26-000008","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001578850-26-000008","line_url":"/filing/0001578850-26-000008","is_derivative":false,"issuer_cik":"0001070081","issuer_name":"PTC THERAPEUTICS, INC.","issuer_ticker":"PTCT","issuer_name_source":null,"issuer_url":"/issuer/0001070081","owner_cik":"0001578850","owner_name":"Almstead Neil Gregory","owner_display_name":"Almstead Neil Gregory","owner_url":"/insider/0001578850","role":"Officer (CHIEF TECHNICAL OPS OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF TECHNICAL OPS OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF TECHNICAL OPS OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3121.0,"shares_display":"3,121","price_per_share":69.36,"price_display":"69.36","price_state":"stated","total_value":216472.56,"total_display":"216,472.56","total_whole":"216,473","shares_owned_after":112140.0,"shares_owned_after_display":"112,140","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-18","filed_date":"2026-02-20","scope":"insider","n_lines":2},{"id":5845226,"accession":"0001578850-26-000006","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001578850-26-000006","line_url":"/filing/0001578850-26-000006","is_derivative":false,"issuer_cik":"0001070081","issuer_name":"PTC THERAPEUTICS, INC.","issuer_ticker":"PTCT","issuer_name_source":null,"issuer_url":"/issuer/0001070081","owner_cik":"0001578850","owner_name":"Almstead Neil Gregory","owner_display_name":"Almstead Neil Gregory","owner_url":"/insider/0001578850","role":"Officer (CHIEF TECHNICAL OPS OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF TECHNICAL OPS OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF TECHNICAL OPS OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":940.0,"shares_display":"940","price_per_share":76.45,"price_display":"76.45","price_state":"stated","total_value":71863.0,"total_display":"71,863.00","total_whole":"71,863","shares_owned_after":115196.0,"shares_owned_after_display":"115,196","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-08","filed_date":"2026-01-12","scope":"insider","n_lines":2},{"id":5801522,"accession":"0001578850-26-000004","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001578850-26-000004","line_url":"/filing/0001578850-26-000004","is_derivative":false,"issuer_cik":"0001070081","issuer_name":"PTC THERAPEUTICS, INC.","issuer_ticker":"PTCT","issuer_name_source":null,"issuer_url":"/issuer/0001070081","owner_cik":"0001578850","owner_name":"Almstead Neil Gregory","owner_display_name":"Almstead Neil Gregory","owner_url":"/insider/0001578850","role":"Officer (CHIEF TECHNICAL OPS OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF TECHNICAL OPS OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF TECHNICAL OPS OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1078.0,"shares_display":"1,078","price_per_share":77.48,"price_display":"77.48","price_state":"stated","total_value":83523.44,"total_display":"83,523.44","total_whole":"83,523","shares_owned_after":116077.0,"shares_owned_after_display":"116,077","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-07","filed_date":"2026-01-08","scope":"insider","n_lines":2},{"id":5801518,"accession":"0001578850-26-000004","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001578850-26-000004","line_url":"/filing/0001578850-26-000004","is_derivative":false,"issuer_cik":"0001070081","issuer_name":"PTC THERAPEUTICS, INC.","issuer_ticker":"PTCT","issuer_name_source":null,"issuer_url":"/issuer/0001070081","owner_cik":"0001578850","owner_name":"Almstead Neil Gregory","owner_display_name":"Almstead Neil Gregory","owner_url":"/insider/0001578850","role":"Officer (CHIEF TECHNICAL OPS OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF TECHNICAL OPS OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF TECHNICAL OPS OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1333.0,"shares_display":"1,333","price_per_share":76.95,"price_display":"76.95","price_state":"stated","total_value":102574.35,"total_display":"102,574.35","total_whole":"102,574","shares_owned_after":117103.0,"shares_owned_after_display":"117,103","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-06","filed_date":"2026-01-08","scope":"insider","n_lines":2},{"id":4968623,"accession":"0001578850-25-000007","txn_seq":24,"anchor":"line-24","filing_url":"/filing/0001578850-25-000007","line_url":"/filing/0001578850-25-000007#line-24","is_derivative":false,"issuer_cik":"0001070081","issuer_name":"PTC THERAPEUTICS, INC.","issuer_ticker":"PTCT","issuer_name_source":null,"issuer_url":"/issuer/0001070081","owner_cik":"0001578850","owner_name":"Almstead Neil Gregory","owner_display_name":"Almstead Neil Gregory","owner_url":"/insider/0001578850","role":"Officer (CHIEF TECHNICAL OPS OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF TECHNICAL OPS OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF TECHNICAL OPS OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":21844.0,"shares_display":"21,844","price_per_share":83.33,"price_display":"83.33","price_state":"stated","total_value":1820260.52,"total_display":"1,820,260.52","total_whole":"1,820,261","shares_owned_after":112891.0,"shares_owned_after_display":"112,891","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-25","filed_date":"2025-11-26","scope":"insider"},{"id":4968618,"accession":"0001578850-25-000007","txn_seq":23,"anchor":"line-23","filing_url":"/filing/0001578850-25-000007","line_url":"/filing/0001578850-25-000007#line-23","is_derivative":false,"issuer_cik":"0001070081","issuer_name":"PTC THERAPEUTICS, INC.","issuer_ticker":"PTCT","issuer_name_source":null,"issuer_url":"/issuer/0001070081","owner_cik":"0001578850","owner_name":"Almstead Neil Gregory","owner_display_name":"Almstead Neil Gregory","owner_url":"/insider/0001578850","role":"Officer (CHIEF TECHNICAL OPS OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF TECHNICAL OPS OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF TECHNICAL OPS OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13514.0,"shares_display":"13,514","price_per_share":82.55,"price_display":"82.55","price_state":"stated","total_value":1115580.7,"total_display":"1,115,580.70","total_whole":"1,115,581","shares_owned_after":134735.0,"shares_owned_after_display":"134,735","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-25","filed_date":"2025-11-26","scope":"insider"},{"id":4968613,"accession":"0001578850-25-000007","txn_seq":22,"anchor":"line-22","filing_url":"/filing/0001578850-25-000007","line_url":"/filing/0001578850-25-000007#line-22","is_derivative":false,"issuer_cik":"0001070081","issuer_name":"PTC THERAPEUTICS, INC.","issuer_ticker":"PTCT","issuer_name_source":null,"issuer_url":"/issuer/0001070081","owner_cik":"0001578850","owner_name":"Almstead Neil Gregory","owner_display_name":"Almstead Neil Gregory","owner_url":"/insider/0001578850","role":"Officer (CHIEF TECHNICAL OPS OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF TECHNICAL OPS OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF TECHNICAL OPS OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9171.0,"shares_display":"9,171","price_per_share":84.42,"price_display":"84.42","price_state":"stated","total_value":774215.82,"total_display":"774,215.82","total_whole":"774,216","shares_owned_after":103720.0,"shares_owned_after_display":"103,720","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-25","filed_date":"2025-11-26","scope":"insider"},{"id":4968609,"accession":"0001578850-25-000007","txn_seq":21,"anchor":"line-21","filing_url":"/filing/0001578850-25-000007","line_url":"/filing/0001578850-25-000007#line-21","is_derivative":false,"issuer_cik":"0001070081","issuer_name":"PTC THERAPEUTICS, INC.","issuer_ticker":"PTCT","issuer_name_source":null,"issuer_url":"/issuer/0001070081","owner_cik":"0001578850","owner_name":"Almstead Neil Gregory","owner_display_name":"Almstead Neil Gregory","owner_url":"/insider/0001578850","role":"Officer (CHIEF TECHNICAL OPS OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF TECHNICAL OPS OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF TECHNICAL OPS OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4834.0,"shares_display":"4,834","price_per_share":83.39,"price_display":"83.39","price_state":"stated","total_value":403107.26,"total_display":"403,107.26","total_whole":"403,107","shares_owned_after":103446.0,"shares_owned_after_display":"103,446","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-25","filed_date":"2025-11-26","scope":"insider"},{"id":4968604,"accession":"0001578850-25-000007","txn_seq":20,"anchor":"line-20","filing_url":"/filing/0001578850-25-000007","line_url":"/filing/0001578850-25-000007#line-20","is_derivative":false,"issuer_cik":"0001070081","issuer_name":"PTC THERAPEUTICS, INC.","issuer_ticker":"PTCT","issuer_name_source":null,"issuer_url":"/issuer/0001070081","owner_cik":"0001578850","owner_name":"Almstead Neil Gregory","owner_display_name":"Almstead Neil Gregory","owner_url":"/insider/0001578850","role":"Officer (CHIEF TECHNICAL OPS OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF TECHNICAL OPS OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF TECHNICAL OPS OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3744.0,"shares_display":"3,744","price_per_share":82.61,"price_display":"82.61","price_state":"stated","total_value":309291.84,"total_display":"309,291.84","total_whole":"309,292","shares_owned_after":108280.0,"shares_owned_after_display":"108,280","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-25","filed_date":"2025-11-26","scope":"insider"},{"id":4968599,"accession":"0001578850-25-000007","txn_seq":19,"anchor":"line-19","filing_url":"/filing/0001578850-25-000007","line_url":"/filing/0001578850-25-000007#line-19","is_derivative":false,"issuer_cik":"0001070081","issuer_name":"PTC THERAPEUTICS, INC.","issuer_ticker":"PTCT","issuer_name_source":null,"issuer_url":"/issuer/0001070081","owner_cik":"0001578850","owner_name":"Almstead Neil Gregory","owner_display_name":"Almstead Neil Gregory","owner_url":"/insider/0001578850","role":"Officer (CHIEF TECHNICAL OPS OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF TECHNICAL OPS OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF TECHNICAL OPS OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3663.0,"shares_display":"3,663","price_per_share":83.41,"price_display":"83.41","price_state":"stated","total_value":305530.83,"total_display":"305,530.83","total_whole":"305,531","shares_owned_after":102582.0,"shares_owned_after_display":"102,582","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-25","filed_date":"2025-11-26","scope":"insider"},{"id":4968594,"accession":"0001578850-25-000007","txn_seq":18,"anchor":"line-18","filing_url":"/filing/0001578850-25-000007","line_url":"/filing/0001578850-25-000007#line-18","is_derivative":false,"issuer_cik":"0001070081","issuer_name":"PTC THERAPEUTICS, INC.","issuer_ticker":"PTCT","issuer_name_source":null,"issuer_url":"/issuer/0001070081","owner_cik":"0001578850","owner_name":"Almstead Neil Gregory","owner_display_name":"Almstead Neil Gregory","owner_url":"/insider/0001578850","role":"Officer (CHIEF TECHNICAL OPS OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF TECHNICAL OPS OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF TECHNICAL OPS OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3095.0,"shares_display":"3,095","price_per_share":85.15,"price_display":"85.15","price_state":"stated","total_value":263539.25,"total_display":"263,539.25","total_whole":"263,539","shares_owned_after":100625.0,"shares_owned_after_display":"100,625","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-25","filed_date":"2025-11-26","scope":"insider"},{"id":4968590,"accession":"0001578850-25-000007","txn_seq":17,"anchor":"line-17","filing_url":"/filing/0001578850-25-000007","line_url":"/filing/0001578850-25-000007#line-17","is_derivative":false,"issuer_cik":"0001070081","issuer_name":"PTC THERAPEUTICS, INC.","issuer_ticker":"PTCT","issuer_name_source":null,"issuer_url":"/issuer/0001070081","owner_cik":"0001578850","owner_name":"Almstead Neil Gregory","owner_display_name":"Almstead Neil Gregory","owner_url":"/insider/0001578850","role":"Officer (CHIEF TECHNICAL OPS OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF TECHNICAL OPS OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF TECHNICAL OPS OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2790.0,"shares_display":"2,790","price_per_share":82.82,"price_display":"82.82","price_state":"stated","total_value":231067.8,"total_display":"231,067.80","total_whole":"231,068","shares_owned_after":106245.0,"shares_owned_after_display":"106,245","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-25","filed_date":"2025-11-26","scope":"insider"},{"id":4968586,"accession":"0001578850-25-000007","txn_seq":16,"anchor":"line-16","filing_url":"/filing/0001578850-25-000007","line_url":"/filing/0001578850-25-000007#line-16","is_derivative":false,"issuer_cik":"0001070081","issuer_name":"PTC THERAPEUTICS, INC.","issuer_ticker":"PTCT","issuer_name_source":null,"issuer_url":"/issuer/0001070081","owner_cik":"0001578850","owner_name":"Almstead Neil Gregory","owner_display_name":"Almstead Neil Gregory","owner_url":"/insider/0001578850","role":"Officer (CHIEF TECHNICAL OPS OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF TECHNICAL OPS OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF TECHNICAL OPS OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2621.0,"shares_display":"2,621","price_per_share":84.54,"price_display":"84.54","price_state":"stated","total_value":221579.34,"total_display":"221,579.34","total_whole":"221,579","shares_owned_after":100825.0,"shares_owned_after_display":"100,825","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-25","filed_date":"2025-11-26","scope":"insider"},{"id":4968581,"accession":"0001578850-25-000007","txn_seq":15,"anchor":"line-15","filing_url":"/filing/0001578850-25-000007","line_url":"/filing/0001578850-25-000007#line-15","is_derivative":false,"issuer_cik":"0001070081","issuer_name":"PTC THERAPEUTICS, INC.","issuer_ticker":"PTCT","issuer_name_source":null,"issuer_url":"/issuer/0001070081","owner_cik":"0001578850","owner_name":"Almstead Neil Gregory","owner_display_name":"Almstead Neil Gregory","owner_url":"/insider/0001578850","role":"Officer (CHIEF TECHNICAL OPS OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF TECHNICAL OPS OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF TECHNICAL OPS OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1757.0,"shares_display":"1,757","price_per_share":84.56,"price_display":"84.56","price_state":"stated","total_value":148571.92,"total_display":"148,571.92","total_whole":"148,572","shares_owned_after":100825.0,"shares_owned_after_display":"100,825","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-25","filed_date":"2025-11-26","scope":"insider"},{"id":4968577,"accession":"0001578850-25-000007","txn_seq":14,"anchor":"line-14","filing_url":"/filing/0001578850-25-000007","line_url":"/filing/0001578850-25-000007#line-14","is_derivative":false,"issuer_cik":"0001070081","issuer_name":"PTC THERAPEUTICS, INC.","issuer_ticker":"PTCT","issuer_name_source":null,"issuer_url":"/issuer/0001070081","owner_cik":"0001578850","owner_name":"Almstead Neil Gregory","owner_display_name":"Almstead Neil Gregory","owner_url":"/insider/0001578850","role":"Officer (CHIEF TECHNICAL OPS OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF TECHNICAL OPS OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF TECHNICAL OPS OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":990.0,"shares_display":"990","price_per_share":83.44,"price_display":"83.44","price_state":"stated","total_value":82605.6,"total_display":"82,605.60","total_whole":"82,606","shares_owned_after":101199.0,"shares_owned_after_display":"101,199","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-25","filed_date":"2025-11-26","scope":"insider"},{"id":4968572,"accession":"0001578850-25-000007","txn_seq":13,"anchor":"line-13","filing_url":"/filing/0001578850-25-000007","line_url":"/filing/0001578850-25-000007#line-13","is_derivative":false,"issuer_cik":"0001070081","issuer_name":"PTC THERAPEUTICS, INC.","issuer_ticker":"PTCT","issuer_name_source":null,"issuer_url":"/issuer/0001070081","owner_cik":"0001578850","owner_name":"Almstead Neil Gregory","owner_display_name":"Almstead Neil Gregory","owner_url":"/insider/0001578850","role":"Officer (CHIEF TECHNICAL OPS OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF TECHNICAL OPS OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF TECHNICAL OPS OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":911.0,"shares_display":"911","price_per_share":82.63,"price_display":"82.63","price_state":"stated","total_value":75275.93,"total_display":"75,275.93","total_whole":"75,276","shares_owned_after":102189.0,"shares_owned_after_display":"102,189","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-25","filed_date":"2025-11-26","scope":"insider"},{"id":4968569,"accession":"0001578850-25-000007","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0001578850-25-000007","line_url":"/filing/0001578850-25-000007#line-12","is_derivative":false,"issuer_cik":"0001070081","issuer_name":"PTC THERAPEUTICS, INC.","issuer_ticker":"PTCT","issuer_name_source":null,"issuer_url":"/issuer/0001070081","owner_cik":"0001578850","owner_name":"Almstead Neil Gregory","owner_display_name":"Almstead Neil Gregory","owner_url":"/insider/0001578850","role":"Officer (CHIEF TECHNICAL OPS OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF TECHNICAL OPS OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF TECHNICAL OPS OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":862.0,"shares_display":"862","price_per_share":83.35,"price_display":"83.35","price_state":"stated","total_value":71847.7,"total_display":"71,847.70","total_whole":"71,848","shares_owned_after":101094.0,"shares_owned_after_display":"101,094","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-25","filed_date":"2025-11-26","scope":"insider"},{"id":4968565,"accession":"0001578850-25-000007","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0001578850-25-000007","line_url":"/filing/0001578850-25-000007#line-11","is_derivative":false,"issuer_cik":"0001070081","issuer_name":"PTC THERAPEUTICS, INC.","issuer_ticker":"PTCT","issuer_name_source":null,"issuer_url":"/issuer/0001070081","owner_cik":"0001578850","owner_name":"Almstead Neil Gregory","owner_display_name":"Almstead Neil Gregory","owner_url":"/insider/0001578850","role":"Officer (CHIEF TECHNICAL OPS OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF TECHNICAL OPS OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF TECHNICAL OPS OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":689.0,"shares_display":"689","price_per_share":82.63,"price_display":"82.63","price_state":"stated","total_value":56932.07,"total_display":"56,932.07","total_whole":"56,932","shares_owned_after":101956.0,"shares_owned_after_display":"101,956","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-25","filed_date":"2025-11-26","scope":"insider"},{"id":4968560,"accession":"0001578850-25-000007","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001578850-25-000007","line_url":"/filing/0001578850-25-000007#line-10","is_derivative":false,"issuer_cik":"0001070081","issuer_name":"PTC THERAPEUTICS, INC.","issuer_ticker":"PTCT","issuer_name_source":null,"issuer_url":"/issuer/0001070081","owner_cik":"0001578850","owner_name":"Almstead Neil Gregory","owner_display_name":"Almstead Neil Gregory","owner_url":"/insider/0001578850","role":"Officer (CHIEF TECHNICAL OPS OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF TECHNICAL OPS OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF TECHNICAL OPS OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":574.0,"shares_display":"574","price_per_share":84.67,"price_display":"84.67","price_state":"stated","total_value":48600.58,"total_display":"48,600.58","total_whole":"48,601","shares_owned_after":100625.0,"shares_owned_after_display":"100,625","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-25","filed_date":"2025-11-26","scope":"insider"},{"id":4968555,"accession":"0001578850-25-000007","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001578850-25-000007","line_url":"/filing/0001578850-25-000007#line-9","is_derivative":false,"issuer_cik":"0001070081","issuer_name":"PTC THERAPEUTICS, INC.","issuer_ticker":"PTCT","issuer_name_source":null,"issuer_url":"/issuer/0001070081","owner_cik":"0001578850","owner_name":"Almstead Neil Gregory","owner_display_name":"Almstead Neil Gregory","owner_url":"/insider/0001578850","role":"Officer (CHIEF TECHNICAL OPS OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF TECHNICAL OPS OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF TECHNICAL OPS OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":289.0,"shares_display":"289","price_per_share":84.61,"price_display":"84.61","price_state":"stated","total_value":24452.29,"total_display":"24,452.29","total_whole":"24,452","shares_owned_after":100805.0,"shares_owned_after_display":"100,805","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-25","filed_date":"2025-11-26","scope":"insider"},{"id":4968551,"accession":"0001578850-25-000007","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001578850-25-000007","line_url":"/filing/0001578850-25-000007#line-8","is_derivative":false,"issuer_cik":"0001070081","issuer_name":"PTC THERAPEUTICS, INC.","issuer_ticker":"PTCT","issuer_name_source":null,"issuer_url":"/issuer/0001070081","owner_cik":"0001578850","owner_name":"Almstead Neil Gregory","owner_display_name":"Almstead Neil Gregory","owner_url":"/insider/0001578850","role":"Officer (CHIEF TECHNICAL OPS OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF TECHNICAL OPS OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF TECHNICAL OPS OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":85.37,"price_display":"85.37","price_state":"stated","total_value":17074.0,"total_display":"17,074.00","total_whole":"17,074","shares_owned_after":100625.0,"shares_owned_after_display":"100,625","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-25","filed_date":"2025-11-26","scope":"insider"},{"id":4968546,"accession":"0001578850-25-000007","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001578850-25-000007","line_url":"/filing/0001578850-25-000007#line-7","is_derivative":false,"issuer_cik":"0001070081","issuer_name":"PTC THERAPEUTICS, INC.","issuer_ticker":"PTCT","issuer_name_source":null,"issuer_url":"/issuer/0001070081","owner_cik":"0001578850","owner_name":"Almstead Neil Gregory","owner_display_name":"Almstead Neil Gregory","owner_url":"/insider/0001578850","role":"Officer (CHIEF TECHNICAL OPS OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF TECHNICAL OPS OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF TECHNICAL OPS OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":85.34,"price_display":"85.34","price_state":"stated","total_value":17068.0,"total_display":"17,068.00","total_whole":"17,068","shares_owned_after":100625.0,"shares_owned_after_display":"100,625","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-25","filed_date":"2025-11-26","scope":"insider"}],"collapsed":true,"next_cursor":"2025-11-25|4968546","ledger_fault":false,"count":{"value":154,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":154,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":154},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001070081","name":"PTC THERAPEUTICS, INC.","url":"/issuer/0001070081","role":"Officer (CHIEF TECHNICAL OPS OFFICER)","n_filings":47,"first_seen":"2014-03-20","last_seen":"2026-07-13"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001578850","retrieved_at":"2026-08-26T20:23:46+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}